Search - tctmd.com

Displaying 61 - 80 of 89

Sort: Relevancy | Date

News Daily News

PROTECT AF at 4 Years: LAA Closure Maintains Efficacy Over Warfarin

Caitlin E. Cox

November 19, 2014

Presentation TCT 2014

TCT 175: Preclinical Study of the Novel Generation of Watchman for Left Atrial Appendage Occlusion

Presenter: Josep Rodés-Cabau, Peter B Sick, Krzysztof Bartus, Dongming Hou

September 16, 2014

Presentation TCT 2014

Percutaneous Left Atrial Access Using the Novel CorQuest HeartXs Device

Presenter: Josep Rodés-Cabau, Carlos E. Ruiz, David L. Brown, Pedro Martinez-Clark

September 14, 2014

Presentation TCT 2014

Percutaneous Left Atrial Appendage Closure for Atrial Fibrillation: Where Are We Compared to New Drugs and Ablation

Presenter: Jose Luis Assad-Morell, Efrain Gaxiola, Matthew J. Price

September 13, 2014

News Daily News

研究发现，应当仅对风险最高的患者使用勒除器进行LAA封堵

Yael L. Maxwell

August 07, 2014

News Daily News

Study Indicates Snare Device for LAA Closure Should Only Be Used in Highest-Risk Patients

Yael L. Maxwell

August 07, 2014

News Daily News

Según Estudio un Dispositivo Cepo para el Cierre del AAI Solo debería de Usarse en los Pacientes de Más Alto Riesgo

Yael L. Maxwell

August 07, 2014

Presentation LAA 2014

Novel Anticoagulants

Presenter: Michael D. Ezekowitz

July 17, 2014

Presentation LAA 2014

Novel LAA Closure Technologies on the Horizon

Presenter: Vivek Y. Reddy

July 17, 2014

News Daily News

PREVAIL Published: Watchman, Warfarin Show Comparable Stroke Protection in A-fib

July 03, 2014

News Daily News

PREVAIL Publicado: Watchman y Warfarina Ofrecen Protección Similar Frente a los ACV en Pacientes con FA

July 03, 2014

News Conference News EuroPCR 2014

Benefit of LAA Closure Becomes Most Evident After 1 Year

Caitlin E. Cox

May 23, 2014

News Conference News TCT 2013

Debate Leaves Little Doubt of LAA Closure Efficacy in the Prevention of Stroke in AF Patients

October 30, 2013

Presentation TCT 2013

Case #3: LAA Closure With a Novel Device

Presenter: Wolfgang Bocksch

October 28, 2013

Presentation TCT 2013

Are Novel LAA Closure Devices (Beyond Watchman) Needed in Germany?

Presenter: Gerald Werner

October 28, 2013

Presentation TCT 2013

Are Novel LAA Closure Devices (Beyond Watchman) Needed in the USA?

Presenter: Saibal Kar

October 28, 2013

News Daily News

Risk Factors for Thrombus Formation on Cardiac Plug in A-fib Patients Identified

Yael L. Maxwell

June 28, 2013

News Daily News

Identificados los Factores de Riesgo para la Formación de Trombos asociados a los Dispositivos Oclusores Cardíacos en Pacientes con FA

Yael L. Maxwell

June 28, 2013

News Daily News

LAA Occlusion More Cost-effective Than Both Warfarin and Dabigatran for A-fib Patients

Yael L. Maxwell

June 07, 2013

News Daily News

Cardiac Plug Shows High Success, Low Complication Rate for LAA Closure

L.A. McKeown

May 28, 2013

Advertisement

PROTECT AF at 4 Years: LAA Closure Maintains Efficacy Over Warfarin

TCT 175: Preclinical Study of the Novel Generation of Watchman for Left Atrial Appendage Occlusion

Percutaneous Left Atrial Access Using the Novel CorQuest HeartXs Device

Percutaneous Left Atrial Appendage Closure for Atrial Fibrillation: Where Are We Compared to New Drugs and Ablation

研究发现，应当仅对风险最高的患者使用勒除器进行LAA封堵

Study Indicates Snare Device for LAA Closure Should Only Be Used in Highest-Risk Patients

Según Estudio un Dispositivo Cepo para el Cierre del AAI Solo debería de Usarse en los Pacientes de Más Alto Riesgo

Novel Anticoagulants

Novel LAA Closure Technologies on the Horizon

PREVAIL Published: Watchman, Warfarin Show Comparable Stroke Protection in A-fib

PREVAIL Publicado: Watchman y Warfarina Ofrecen Protección Similar Frente a los ACV en Pacientes con FA

Benefit of LAA Closure Becomes Most Evident After 1 Year

Debate Leaves Little Doubt of LAA Closure Efficacy in the Prevention of Stroke in AF Patients

Case #3: LAA Closure With a Novel Device

Are Novel LAA Closure Devices (Beyond Watchman) Needed in Germany?

Are Novel LAA Closure Devices (Beyond Watchman) Needed in the USA?

Risk Factors for Thrombus Formation on Cardiac Plug in A-fib Patients Identified

Identificados los Factores de Riesgo para la Formación de Trombos asociados a los Dispositivos Oclusores Cardíacos en Pacientes con FA

LAA Occlusion More Cost-effective Than Both Warfarin and Dabigatran for A-fib Patients

Cardiac Plug Shows High Success, Low Complication Rate for LAA Closure

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content